Conquering Diseases

Study Of An Investigational Drug For Epidermolysis Bullosa

Description

Seeking men and women who have wounds on their skin from Epidermolysis Bullosa.

Overview

Participants in this study will either get a gel containing the investigational drug or a placebo (gel without any medicine) to apply to their wound every day for 8 weeks. There will be up to 7 study visits over 36 weeks.

What we're hoping for

We are studying whether an investigational drug is safe and effective for use on wounds caused by Epidermolysis Bullosa.

Additional Information

ClinicalTrials.gov Identifier: NCT05529134

 Principal Investigator

Karen  Wiss, MD

UMass Memorial Health

 Study Contact

Dermatology  Research

774-455-4758

DermResearch@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989